Log in to save to my catalogue

Expression of cytokeratin 19 in prostatic adenocarcinoma: a systematic review

Expression of cytokeratin 19 in prostatic adenocarcinoma: a systematic review

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_44cbbbd1d52645d4be7933f9392d2210

Expression of cytokeratin 19 in prostatic adenocarcinoma: a systematic review

About this item

Full title

Expression of cytokeratin 19 in prostatic adenocarcinoma: a systematic review

Publisher

England: BioMed Central Ltd

Journal title

BMC cancer, 2025-01, Vol.25 (1), p.52-13, Article 52

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Cytokeratins are intracellular proteins known as diagnostic biomarkers or prognostic factors for certain cancers. Cytokeratin 19 (CK-19) expression has been proven to have prognostic value for some cancers, but its relationship with others, such as prostate cancer (PCa), remains unclear. This systematic review article aimed to examine the relations...

Alternative Titles

Full title

Expression of cytokeratin 19 in prostatic adenocarcinoma: a systematic review

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_44cbbbd1d52645d4be7933f9392d2210

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_44cbbbd1d52645d4be7933f9392d2210

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-025-13456-x

How to access this item